2Verso M,Agnelli G. Venous thromboembolism associated with long-termuse of central venous catheters in cancer patients[J]. J Clin Oncol, 2003,21 ( 1 9) : 3665-3675.
3Svoboda P, Barton RP, Barbarash OL, et al. Recombinant uroki- nase issafe and effective in restoring catheter patency to occlud- ed central venousdevices:a multi-center,international trial[J]. Crit Care Med,2004,32(10) : 1990-1996.
5Deutsch G B, Sathyanarayana S A, Singh N, et al. Ultra-sound-guided Placement of Midline Catheters in the Surgi-cal Intensive Care Unit: A Cost-effective Proposal for Time-ly Central Line Removal[ J ]. J Surg Res,2014,191 (1):1-5.D01:10.1016/j.jss.2013.03.047.
7O ’ Grady N P, Alexander M, Bums L A, et al. Guidelines forthe Prevention of Intravascular Catheter-related Infections[J ]. Am J Infect Control, 2011,39(4Suppll):1-34.DOI:10.1016/j.ajic.2011.01.003.
8Caparas J V, Hu J P. Safe Administration of Vancomycinthrough a Novel Midline Catheter: A Randomized, Prospec-tive Clinical Trial[J]. J Vase Access, 2014,15(4):251-256.D01:10.5301/jva.5000220.
9Comely 0 A, Bethe U, Pauls R, et al. Peripheral TeflonCatheters: Factors Determining Incidence of Phlebitis andDuration of Cannulation[ J ]. Infect Control Hosp Epidemiol,2002,23(5):249-253.DOI:10.1086/502044.
10Tagalakis V, Kahn S R,Libman M, et al. The Epidemiologyof Peripheral Vein Infusion Thrombophlebitis: A CriticalReview[J].Am J Med, 2002,113(2):146-151.DOI:org/10.1016/S0002-9343(02)01163-4.
